| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |